In The News

On February 20, 2014 Excellus Blue Cross Blue Shield revised their coverage policy to now include SBRT for the treatment of prostate cancer for centers contracted with them in 31 counties of Upstate New York. Excellus BCBS is the largest non-profit private insurer in upstate New York, covering 1.8 million lives.

The newly updated policy covers a variety of intracranial indications for stereotactic radiosurgery (SRS) including brain tumors, AVM, acoustic neuroma, trigeminal neuralgia, and movement disorders. Extracranial indications treated with stereotactic body radiation therapy (SBRT) now covered by Excellus include prostate cancer in addition to the treatment of tumors in the spine, liver, lung, pancreas, adrenal gland, head and neck, and renal cell carcinoma. The policy can be accessed at: Click Here